Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian M Olson

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
The Prostate|September 21, 2007
Antibody and T-cell responses specific for the androgen receptor in patients with prostate cancerBrian M Olson, Douglas G McNeel
Cancer Immunology, Immunotherapy : CII|February 26, 2011
CD8+ T cells specific for the androgen receptor are common in patients with prostate cancer and are able to lyse prostate tumor cellsBrian M Olson, Douglas G McNeel
Frontiers in Oncology|May 9, 2013
Monitoring regulatory immune responses in tumor immunotherapy clinical trialsBrian M Olson, Douglas G McNeel
Methods in Molecular Biology (Clifton, N.J.)|July 2, 2009
Methods for constructing and evaluating antitumor DNA vaccinesBrian M Olson, Douglas G McNeel
Open Access Journal of Urology|November 8, 2013
Sipuleucel-T: immunotherapy for advanced prostate cancerBrian M Olson, Douglas G McNeel
Expert Review of Vaccines|December 20, 2012
Antigen loss and tumor-mediated immunosuppression facilitate tumor recurrenceBrian M Olson, Douglas G McNeel
Frontiers in Immunology|October 24, 2013
Interleukin 35: a key mediator of suppression and the propagation of infectious toleranceBrian M Olson, Jeremy A Sullivan, William J Burlingham
Expert Review of Vaccines|December 21, 2012
Vaccination using peptides spanning the SYT-SSX tumor-specific translocationJordan E Bloom, Douglas G McNeel, Brian M Olson
Oncoimmunology|July 30, 2016
Antitumor vaccination of prostate cancer patients elicits PD-1/PD-L1 regulated antigen-specific immune responsesBrian T Rekoske, Brian M Olson, Douglas G McNeel
Journal for Immunotherapy of Cancer|July 19, 2017
Pretreatment antigen-specific immunity and regulation - association with subsequent immune response to anti-tumor DNA vaccinationLaura E Johnson, Brian M Olson, Douglas G McNeel
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
The Prostate|September 21, 2007
Antibody and T-cell responses specific for the androgen receptor in patients with prostate cancerBrian M Olson, Douglas G McNeel
Cancer Immunology, Immunotherapy : CII|February 26, 2011
CD8+ T cells specific for the androgen receptor are common in patients with prostate cancer and are able to lyse prostate tumor cellsBrian M Olson, Douglas G McNeel
Frontiers in Oncology|May 9, 2013
Monitoring regulatory immune responses in tumor immunotherapy clinical trialsBrian M Olson, Douglas G McNeel
Methods in Molecular Biology (Clifton, N.J.)|July 2, 2009
Methods for constructing and evaluating antitumor DNA vaccinesBrian M Olson, Douglas G McNeel
Open Access Journal of Urology|November 8, 2013
Sipuleucel-T: immunotherapy for advanced prostate cancerBrian M Olson, Douglas G McNeel
Expert Review of Vaccines|December 20, 2012
Antigen loss and tumor-mediated immunosuppression facilitate tumor recurrenceBrian M Olson, Douglas G McNeel
Frontiers in Immunology|October 24, 2013
Interleukin 35: a key mediator of suppression and the propagation of infectious toleranceBrian M Olson, Jeremy A Sullivan, William J Burlingham
Expert Review of Vaccines|December 21, 2012
Vaccination using peptides spanning the SYT-SSX tumor-specific translocationJordan E Bloom, Douglas G McNeel, Brian M Olson
Oncoimmunology|July 30, 2016
Antitumor vaccination of prostate cancer patients elicits PD-1/PD-L1 regulated antigen-specific immune responsesBrian T Rekoske, Brian M Olson, Douglas G McNeel
Journal for Immunotherapy of Cancer|July 19, 2017
Pretreatment antigen-specific immunity and regulation - association with subsequent immune response to anti-tumor DNA vaccinationLaura E Johnson, Brian M Olson, Douglas G McNeel
Pageof 3